The Context
On 22–23 June 2026, OFAC issued a 60‑day general license authorising Iran to produce, sell and deliver crude oil and petroleum products until 21 August 2026. The arithmetic is stark: this waiver permits dollar‑denominated transactions for the first time in over four years, and the Wall Street Journal projects it could unlock over $60 billion annually in Iranian oil revenue. The license explicitly allows settlement in U.S. dollar‑denominated funds. This is not a dismantling of sanctions—it is a temporary, scope‑limited carve‑out. Yet the market reaction has treated it as a de facto normalisation. The underlying failure is quantified by the Foundation for Defense of Democracies: in October 2025, 53 vessels carried Iranian oil, 39 of which were already under U.S. sanctions. The gap between legal prohibition and actual enforcement is now a chasm.
The Risk
For directors, the liability arithmetic is simple. The license expires on 21 August 2026. Any transaction that falls outside its precise terms—any Iranian oil trade not covered by the waiver, any facilitation through a non-licensed channel—remains fully prohibited under IEEPA (50 U.S.C. §1705) and the Iranian Transactions and Sanctions Regulations (31 C.F.R. §560.204). Civil penalties can reach the greater of the statutory maximum per violation or twice the transaction value. Criminal penalties for willful violations: up to 20 years’ imprisonment and $1 million per count. Directors who approve or knowingly tolerate off‑license deals expose themselves to direct conspiracy and aiding‑and‑abetting liability. The Atlantic Council’s sanctions brief is explicit: “Temporary US licenses allowing Russian and Iranian oil sales are backfiring by generating major revenue windfalls for sanctioned regimes.” A board that treats this waiver as a blanket green light is authorising a governance gap that regulators, prosecutors and shareholder litigants will measure in billions. Under New Zealand’s Companies Act 1993, directors who fail to exercise due diligence in overseeing sanctions compliance may face claims for breach of fiduciary duty and gross negligence.
The Control
The immediate strategic response is to impose a board‑level freeze on any new or expanded Iran‑linked business until a documented, license‑by‑license legal analysis is completed. Every dollar‑clearing bank and U.S.‑linked entity in your group must verify that all Iranian oil transactions are covered by the 21 August waiver—and that no transaction extends beyond its expiry. This is not a compliance tick‑box; it is a mathematical requirement. The waiver’s dollar‑denominated provision places global clearing banks at the chokepoint. Directors must demand a written opinion from external sanctions counsel confirming the precise scope of each license and the audit trail for every transaction. The cost of getting this wrong is not theoretical: it is the difference between a $60 billion revenue stream for Iran and a multi‑billion‑dollar enforcement action against your institution.
The Challenge
These are the critical questions you should be raising at the board table:
| Has management obtained a written, externally‑reviewed legal opinion confirming that every current and planned Iranian oil transaction falls within the precise terms of the 21 August waiver—and what is the documented audit trail for each transaction? | |
| What is the board’s contingency plan for the moment the waiver expires on 21 August—specifically, how will we unwind any in‑flight transactions and ensure no residual dollar‑clearing exposure to Iranian counterparties? | |
| Can the board demonstrate, through board minutes and compliance committee records, that it has exercised due diligence in overseeing sanctions screening, license‑condition checks and counterparty due diligence—or does the record show a governance gap that regulators could exploit? |